Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: CHEMOGENICS BIOPHARMA, LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-21 to 2023-12-20
Current total value of award: $23540
Description: EVALUATING PHARMACOKINETICS OF ALDOMETANIB IN MICE